Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New app aims to cut hospital stays for lung patients

NCT ID NCT07625176

Knowledge-focused Sponsor: Zealand University Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only This study
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a smartphone app that guides doctors through the best steps for diagnosing and treating pleural disease (fluid, infection, or collapsed lung) can reduce the number of days patients spend in the hospital. About 828 adults in Denmark with these conditions will take part. The app is designed to help non-specialist doctors make faster, evidence-based decisions from arrival to discharge.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 828 people

The number the study aims to enrol. It can still change while the study runs.

Started

Apr 2026

Expected to finish

Oct 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: One or more of the following, relevante ICD-10 codes for either spontaneous pneumothorax, pleural effusion or pleural infection. Spontaneous pneumothorax: * DJ93 * DJ930 * DJ931 * DJ938 * DJ939 Pleural effusion: * DJ90 * DJ909 * DJ919 * DJ91 * DJ940 * DJ948 * DJ948A * DJ949 * DC782 Pleural infection: * DJ86 * DJ860 * DJ860 Exclusion Criteria: * Traumatic pneumothorax (including iatrogenic pneumothorax) * Hemothorax

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Pleural diseases are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

familial spontaneous pneumothorax pleural disorder Pleural Effusion pleural empyema pneumothorax

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Pleural diseases Pleural effusion Pleural infection Pneumothorax spontaneous primary Pneumothorax spontaneous secondary

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    10 sites. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Aalborg University Hospital

    Aalborg, 9000, Denmark

  • Aarhus University Hospital

    Aarhus, 8200, Denmark

  • Amager Hospital

    Amager, 2300, Denmark

  • Esbjerg Hospital

    Esbjerg, 6700, Denmark

  • Hvidovre Hospital

    Hvidovre, 2650, Denmark

  • Kolding Hospital

    Kolding, 6000, Denmark

  • North Zealand Hospital, Hillerød

    Hillerød, 3400, Denmark

  • Odense University Hospital

    Odense, 5000, Denmark

  • Slagelse Hospital

    Slagelse, 4200, Denmark

  • Zealand University Hospital, Køge

    Køge, 4600, Denmark

More trials for these conditions

Other studies related to the condition(s) this trial covers.